Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome.


OBJECTIVE There is evidence of preclinical cardiovascular disease even in young women with polycystic ovary syndrome (PCOS). The aim of our study was to assess and compare the effects of metformin (MET) and rosiglitazone (ROSI) on endothelial function in PCOS patients. METHODS For 6 months, 26 women with PCOS received either MET or ROSI. Blood samples for… (More)
DOI: 10.1530/EJE-08-0507


2 Figures and Tables